Group therapy for adolescents who repeatedly harm themselves

ISRCTN ISRCTN20496110
DOI https://doi.org/10.1186/ISRCTN20496110
Secondary identifying numbers 1727/1072
Submission date
16/06/2009
Registration date
19/08/2009
Last edited
06/04/2011
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Jonathan Green
Scientific

Jean McFarlane Building
Room 4.321
University of Manchester
Oxford Road
Manchester
M13 9PL
United Kingdom

Phone +44 (0)161 275 2000
Email Jonathan.green@manchester.ac.uk

Study information

Study designTwo arm single-blinded randomised allocation trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleA two arm single blinded randomised allocation trial of a manualised group therapy in addition to usual care compared with usual care alone for adolescents who repeatedly harm themselves
Study acronymASSIST
Study objectives1. To test the effect of the addition of a manualised group therapy intervention to usual care when treating adolescent repeated self harm
2. To explore the costs and cost-effectiveness of usual care plus group therapy compared to usual care alone
Ethics approval(s)Multi-centre Research Ethics Committee (MREC) approved in March 2002 (ref: 01-8-8)
Health condition(s) or problem(s) studiedSelf-harm (deliberate overdoses, cutting, burning, banging head, ligatures)
InterventionIntervention:
The experimental group therapy intervention is a manualised treatment specifically designed for adolescents who harmed themselves. The group treatment is based on cognitive behaviour and problem solving techniques. Techniques used in the group integrated empirically based conceptual approaches in common clinical practice within the NHS and advocated by several opinion leaders in the field of deliberate self harm. Participants were asked to attend four group therapy sessions. After this, they can access the group for as long as they are open to CAMHS.

Comparator - Routine Care:
Clinical centres provide routine care that they would normally provide to these patients. Treatment as usual is undertaken by the local CAMHS Team using established protocols and clinical practice. Centres agree that routine care will not include any group intervention.

For both arms of the trial, treatment was given for as long as the Care Manager though it was clinically needed. Some participants were in treatment for over a year.
Intervention typeOther
Primary outcome measureFrequency and severity of episodes of self harm assessed using an adapted self harm interview schedule. Steps will be taken with the interview schedule to minimise a recall bias towards more recent events and to get a clear picture of the pattern of self harm over the previous year. The self harm interview will be conducted by research assessors (blinded to treatment allocation) and additionally (to allow for reporting bias from young people) clinicians involved with the young person will also undertake the same interview.
Secondary outcome measures1. Time to first and second repetition, number of severe suicidal acts (defined by medical risk of death)
2. Depression measured using the Moods and Feelings Questionnaire (MFQ)
3. Suicidality measured using the Suicidale Ideation Questionnaire
4. Global outcome assessed by the health of the nation outcome scales for children and adolescents (HoNOSCA)
5. Psychosocial stress assessed using the Kiddie Schedule for Affective Disorders and Scizophrenia (K-SADS)
6. Cost benefit analysis measured using the Service Use Inventory

All the above administered at baseline, 6 and 12 months. At 3 months an assessment to measure emerging personality problems was undertaken (SCID II).
Overall study start date01/08/2002
Completion date01/06/2007

Eligibility

Participant type(s)Patient
Age groupChild
Lower age limit12 Years
Upper age limit17 Years
SexBoth
Target number of participants156 cases in each group, we need to randomise 372 cases
Key inclusion criteria1. Aged 12 - 17 years, either sex
2. Referred to mental health services in Greater Manchester following self-harm
3. The adolescent reports that in the last year he or she has harmed themselves on at least one other occasion
Key exclusion criteria1. The adolescent cannot attend groups (e.g., in secure care)
2. Has a psychotic or eating disorder
3. Unlikely to benefit from groups (e.g., learning problems)
4. Non-English speakers
Date of first enrolment01/08/2002
Date of final enrolment01/06/2007

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Jean McFarlane Building
Manchester
M13 9PL
United Kingdom

Sponsor information

University of Manchester (UK)
University/education

Oxford Road
Manchester
M13 9PL
England
United Kingdom

Phone +44 (0)161 275 2000
Email david.walkden@manchester.ac.uk
Website http://www.manchester.ac.uk/
ROR logo "ROR" https://ror.org/027m9bs27

Funders

Funder type

Charity

Mental Health Foundation (UK) - PPP Healthcare Trust (ref: 1727/1072)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/04/2011 Yes No